Found in: Austria Australia Canada Cyprus Spain France Hong Kong Netherlands Singapore United Kingdom United States

Active ingredients

Active Ingredient

Risedronic acid is a pyridinyl bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption. The bone turnover is reduced while the osteoblast activity and bone mineralisation is preserved.

Medicine classification

ATC Code
Risedronic acid
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates


FDA, National Drug Code (US)
Identifier(s): 0430-0472, 0430-0478
Health Products and Food Branch (CA)
Identifier(s): 02246896, 02316838, 02370417
Health Sciences Authority (SG)
Identifier(s): 11569P, 12284P, 13948P
Pharmaceutical Benefits Scheme (AU)
Identifier(s): 2191H, 4443W, 8481J, 8482K, 8972F, 9391G
Z-Index G-Standaard PRK (NL)
Identifier(s): 59064, 68888, 85995
Base de données publique des médicaments (FR)
Identifier(s): 60399454, 64144419, 64392560, 65740030, 69716824
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 63207, 63208, 65167, 69696, 81940
Medicines & Healthcare Products Regulatory Agency (GB)
Identifier(s): 132111, 138234, 140396, 140398, 180498, 19160, 198638, 40287
Department of Health Drug Office (HK)
Identifier(s): 50537, 60147